Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Idaho for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Idaho only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Idaho (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Denton Roberts (NPI 1699742395)

Field	Value
Entity Type	Individual
Organization	Denton Roberts
Address	13923 W Wainwright Dr
City	Boise
State	ID
ZIP	83713
Taxonomy	Ophthalmology Physician
NPI Enumerated	March 2, 2006

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the sole payer presence on file: total Medicare revenue is $1.6M and there is no Medicaid billing on file (“none below”), meaning the practice is effectively single‑payer (Medicare) in scope based on available claims. The provider’s NPI was enumerated 2006-03-02 (~20 years ago), indicating long-standing enrollment and continuity of Medicare billing activity.

Revenue is highly concentrated in intravitreal drug and injection services: J0178, J2777, and 67028 together account for 78.4% of Medicare revenue. J0178 alone represents $817.2K (50.0% of revenue; 1.2K claims, $689 avg paid/claim), while J2777 contributes $368.9K (22.6%; 12.7K claims, $29 avg paid/claim) and 67028 adds $95.4K (5.8%; 1.1K claims, $83 avg paid/claim), which signals a practice focused on retinal injections and related procedures.

The mix of top codes and their descriptions point to a retina-centered ophthalmology practice that manages medical retinal disease with anti‑VEGF and newer intravitreal agents. The presence of multiple drug codes (J0178, J2777, J2778, J2781) alongside procedure code 67028 (intravitreal injection procedure) supports an operational model built around frequent injection visits and associated in-office procedures for conditions like wet AMD and other retinal disorders.

On competitive standing for principal revenue drivers, the provider is a modest national participant rather than a dominant provider: J0178 ranks #1107 of 3204 providers (65th percentile; typical, unremarkable volume), J2777 ranks #827 of 2039 (59th percentile; typical, unremarkable volume), and 67028 ranks #1191 of 4255 (72th percentile; typical, unremarkable volume). These ranks indicate solid but not leading national volume for the drug and injection services that generate most revenue.

The practice shows above‑typical activity in diagnostic imaging and mid‑to‑high complexity E/M visits: 92134 has 2.2K claims ($57.9K revenue) and ranks #844 of 26868 providers (97th percentile; notably above typical national volume), while 99214 has 875 claims ($70.9K revenue) and ranks #15834 of 479517 providers (97th percentile; notably above typical national volume). This combination suggests a high diagnostic throughput and frequent follow-up visits consistent with ongoing management of retinal disease.

There are notable E/M and new‑patient outliers that merit attention: 99204 is an extreme outlier nationally (213 claims, $22.4K revenue; 98th percentile) and 99214 is notably above typical (875 claims, $70.9K revenue; 97th percentile). The unusually high relative volume of 99204 (new patient visits) could reflect an elevated referral intake, a practice focus on new consults for retinal disease, or local market dynamics driving new patient evaluations.

Although the provider bills several high‑cost intravitreal drugs, their national percentiles vary: J2778 (ranibizumab) is at the 28th percentile (381 claims, $69.7K) and J2781 (pegcetacoplan) is at the 43th percentile (497 claims, $59.6K), indicating selective use of alternative agents alongside the dominant J0178 and J2777. The presence of multiple therapeutic agents in the top codes signals treatment of a range of retinal conditions and adoption of newer therapies, but not dominance of those alternatives relative to national peers.

From a payer‑mix and operational risk perspective, the absence of Medicaid billing (stated as none) means the provider’s publicly reported outpatient revenue is concentrated in Medicare, which reduces Medicaid exposure but increases reliance on Medicare reimbursement trends for intravitreal drugs and imaging. Analysts should consider the implications of this single‑payer concentration for network contracting, access for Medicaid beneficiaries, and sensitivity to Medicare drug/payment policy changes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

12 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,190	$690	$817.2K
J2777	Injection, faricimab‑svoa, 0.1 mg	12,720	$30	$368.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,150	$80	$95.4K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	880	$80	$70.9K
J2778	Injection, ranibizumab, 0.1 mg	380	$180	$69.7K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	500	$120	$59.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,230	$30	$57.9K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	410	$90	$38K
J7999	Compounded drug, not otherwise classified	320	$70	$22.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	210	$110	$22.4K

Showing 1–10 of 12

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 12 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Idaho Distribution

Denton Roberts — 3 of 12 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Idaho

Full comparison — all codes billed, vs. state median

12 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	6	20	670	$690	$541.7K
J2777	4	10	8,640	$30	$454.7K
J2778	4	10	1,190	$180	$352.5K
J2781	5	10	990	$120	$153.8K
67028	7	30	470	$90	$66.6K
67108	5	10	10	$1,130	$19.2K
J7999	6	20	200	$70	$18.9K
92014	40	230	120	$70	$15.5K
99214	21	2,690	90	$70	$10.4K
92134	3	190	60	$30	$5.9K

Showing 1–10 of 12

Related Providers

Other providers that share a Tax Identification Number (TIN) with Denton Roberts, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
James Earl	ID	Retina Specialist (Ophthalmology) Physician	$3.1M	$0
Daniel Gealy	TX	Ophthalmology Physician	$923.7K	$0
Retina Specialists Of Idaho Partners, PLLC	ID	Retina Specialist (Ophthalmology) Physician	$0	$363.2K

Nearby Providers

Other providers in the same ZIP code as Denton Roberts, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Rise, Inc	ID	Voluntary or Charitable Agency	$0	$263.8M
Trivium Life Services Mountain West, LLC	ID	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$3M
Trinity Mountain Health	ID	Home Health Agency	$0	$2.2M
Boise Toothtown Dentistry For Kids PLLC	ID	Pediatric Dentistry	$0	$2.1M
Mountain View Behavioral Health, LLC	ID	Community/Behavioral Health Agency	$0	$1.7M
Edgewood Spring Creek Boise, LLC	ID	Assisted Living Facility	$0	$1.6M
Edgewood Spring Creek Eagle Island LLC	ID	Assisted Living Facility	$0	$1.3M
Zrj Inc	ID	Physical Therapist	$0	$1.2M
Community Partnerships Of Idaho, Inc.	ID	Community/Behavioral Health Agency	$0	$1.2M
Blair Pediatric Dentistry PC	ID	Pediatric Dentistry	$0	$669.4K

Denton Roberts — Billing Profile & Reimbursement Data

Sign up for Denton Roberts — Billing Profile & Reimbursement Data policy alerts

Denton Roberts — Billing Profile & Reimbursement Data

Sign up for Denton Roberts — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References